Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2003
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037912A2 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037266A2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003US20030088057 Peptide substrates phosphorylated by p21-activaged protein kinase statement regarding federally sponsored reasearch or development
05/08/2003US20030087813 Antihistamines; respiratory system disorders
05/08/2003US20030087811 Compounds and methods for cancer therapy
05/08/2003US20030087407 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/08/2003US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087255 Peptides which stimulate the immune response and tissue regeneration
05/08/2003US20030086939 Methods to improve immunogenicity of antigens and specificity of antibodies
05/08/2003CA2466326A1 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003CA2466152A1 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003CA2465639A1 Tumor antigen
05/08/2003CA2465316A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/07/2003EP1307609A2 Continuous electrolytic pickling method for metallic products using alternate current supplied cells
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307472A1 Peptides capable of functioning as mimotopes for estradiol analytes
05/06/2003US6560542 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
05/06/2003US6559282 Induction of antibodies against leutenizing hormone releasing hormone in mammals; obtain mammal, administer modulator, monitor immune response, evaluate for prevention of infections
05/06/2003US6559281 Non-naturally occurring synthetic lytic peptides
05/06/2003US6559280 Controlling protein levels in eucaryotic organisms
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6558671 Tumor specific immunogens of modified naturally occurring epitope SEQ ID NO:19, 37 or 10
05/06/2003US6558649 Vitronectin receptor antagonist pharmaceuticals
05/02/2003EP1306371A1 Cyclic imines
05/02/2003EP1306005A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305338A2 Modified peptides with increased potency
05/02/2003EP1305336A2 Therapeutic anti-melanoma compounds
05/02/2003EP1305332A2 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid
05/02/2003EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
05/01/2003WO2003035697A1 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
05/01/2003WO2003035675A1 Biologically active peptides and their use for repairing injured nerves
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035060A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003WO2003000277A3 Antimicrobial peptides
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003US20030083262 Methods and compositions for treating inflammatory disorders
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083240 Bactericides
05/01/2003US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation
05/01/2003US20030083238 Cyclic hexapeptide derivatives
05/01/2003US20030083236 Myelopeptides and their therapeutic use
05/01/2003US20030083235 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents
05/01/2003US20030082831 Apparatus for use in the synthesis of preferential biopolymers
05/01/2003US20030082804 Peptide for use in the treatment of cell proliferation disorders
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082654 Novel cancer marker and uses therefor in the diagnosis of cancer
05/01/2003US20030082524 Isolation of peptide which immunologically mimics streptococci protein for use in vaccine development; prepare antibody sample, incubate with phage display library, detect bound phage, isolate and recover phage
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082201 Genetic engineering; polymerase chain reaction
05/01/2003US20030082200 Protein binding to immobilized vitronectin
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082186 Synthetic peptides that bind to the hepatitis B virus core and E antigens
05/01/2003US20030082171 Deafness therapy, prevention; mylein protein vaccine
05/01/2003CA2462163A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
04/2003
04/30/2003CN1414971A Depsipeptide and congeners thereof for use as immunosuppressants
04/30/2003CN1414871A Placental human necerokinin B precursor
04/29/2003US6555692 Polylactams having imidazole or pyrrole rings specifically bind with subnanomolar affinity to a predetermined DNA sequence; use in molecular biology and diagnostic medicine; gene expression control; target the minor groove of B-form
04/29/2003US6555651 Ligand binding site of rage and uses thereof
04/29/2003US6555650 Cyclic analogs of histatins
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/29/2003US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening
04/29/2003US6555091 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
04/29/2003CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
04/24/2003WO2003034791A1 Mounting arrangement for auxiliary burner or lance
04/24/2003WO2003034071A2 A method of forming a dynamic combinatorial library using a scaffold
04/24/2003WO2003033671A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003WO2003033644A2 Peptide useful in immunomodulation
04/24/2003WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists
04/24/2003WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents
04/24/2003WO2003033526A2 Synthesis of cyclosporin analogs
04/24/2003WO2003033525A1 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
04/24/2003WO2003033524A2 Peptidyl ketones as inhibitors of dpiv
04/24/2003WO2003033437A2 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained
04/24/2003WO2003033021A1 Use of peptide vectors to improve the immune response to antigens
04/24/2003WO2003033017A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
04/24/2003WO2003033011A2 Repetitive motifs from salivary proline rich proteins, mucin and collagen
04/24/2003WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases
04/24/2003WO2003032964A2 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
04/24/2003WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents
04/24/2003WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents
04/24/2003WO2003032900A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
04/24/2003WO2002079397A3 Virus derived antimicrobial peptides
04/24/2003WO2002047710A3 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer
04/24/2003WO2002036798A3 Inhibitors of transglutaminases
04/24/2003WO2001098540A3 Recombination modulators and methods for their production and use
04/24/2003US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
04/24/2003US20030078374 Complementary peptide ligands generated from the human genome
04/24/2003US20030078368 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
04/24/2003US20030078202 Receptor derived peptides involved in modulation of response to ligand binding
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 423